{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Piperacillin-tazobactam",
        "BD Phoenix\u2122 Automated Microbiology System piperacillin-tazobactam",
        "BD Phoenix\u2122M Automated Microbiology System for use with the antimicrobial agent piperacillin-tazobactam"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K061869",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K060324",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "August 1, 2006",
    "Summary Letter Received Date": "July 3, 2006",
    "Submission Date": "June 29, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Piperacillin-tazobactam"
    ],
    "Specimen Type(s)": [
        "Pure culture of Gram-negative bacteria",
        "Pure culture of Gram-positive bacteria",
        "Enterobacteriaceae",
        "Non-Enterobacteriaceae",
        "Staphylococcus",
        "Enterococcus",
        "Streptococcus"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution test",
        "Redox indicator detection",
        "Turbidity measurement"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Identification (ID) testing"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix\u2122M Automated Microbiology System addition of piperacillin-tazobactam for antimicrobial susceptibility testing using broth microdilution and redox/turbidity detection",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of most Gram-negative and Gram-positive bacteria from pure culture, including Staphylococcus, Enterococcus, and Streptococcus, using piperacillin-tazobactam in Gram positive ID/AST or AST only Phoenix panels",
    "fda_folder": "Microbiology"
}